ARCHIVES

Hammer Blast GAO Report As ”Gobblygook”

This article is from The Cancer Letter archive.

Vol. 13 No. 24 | June 12, 1987

Download PDF Visit The Full Archive

Related Articles

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

March 2, 2012

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Panel Resumes Deliberations

January 4, 1980

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Dole Visits Roswell Park, Hails PSA Test

January 28, 1994